MedCity News November 4, 2025
Katie Adams

Jennifer Thompson, Medtronic’s vice president of U.S. aortic sales, detailed how AI is transforming medical device commercialization during a fireside chat at Reuters’ MedTech conference. The technology is helping teams identify patients, optimize their sales deployment and discover care bottlenecks.

The process of commercializing a new medical device is typically quite a long one. It usually takes at least 10 years to complete the journey from conception to FDA approval, noted medtech sales veteran Jennifer Thompson during a fireside chat on Monday at Reuters’ MedTech conference in Boston.

Thompson has worked at Medtronic for nearly 20 years, currently serving as vice president of sales for the U.S. within the medical device giant’s aortic unit. When she first joined the company...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Medical Devices, Technology, Trends
The medical device trends doctors can expect to see in 2026
Are Biofeedback Devices the Key to Stopping Senior Stress?
Consolidation trends in the medical device industry in 2026
This Week in European MedTech and HealthTech: 23rd January 2026
Intuitive pushes into cardiac robotic surgery, ASCs

Share Article